Exact Mass: 200.1332

Exact Mass Matches: 200.1332

Found 186 metabolites which its exact mass value is equals to given mass value 200.1332, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Medetomidine

Dexmedetomidine

C13H16N2 (200.1313)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].

   

tetrahydrozoline

4,5-Dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole

C13H16N2 (200.1313)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].

   

Dexmedetomidine

4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole

C13H16N2 (200.1313)


Dexmedetomidine is only found in individuals that have used or taken this drug. It is an agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine. [PubChem]Dexmedetomidine is a specific and selective alpha-2 adrenoceptor agonist. By binding to the presynaptic alpha-2 adrenoceptors, it inhibits the release if norepinephrine, therefore, terminate the propagation of pain signals. Activation of the postsynaptic alpha-2 adrenoceptors inhibits the sympathetic activity decreases blood pressure and heart rate. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].

   

(S)-9-Hydroxy-10-undecenoic acid

(S)-9-Hydroxy-10-undecenoic acid

C11H20O3 (200.1412)


(S)-9-Hydroxy-10-undecenoic acid is found in green vegetables. (S)-9-Hydroxy-10-undecenoic acid is a constituent of Corchorus olitorius (Jews mallow)

   

Clarycet

4-Methyl-2-propyloxan-4-yl acetic acid

C11H20O3 (200.1412)


Clarycet is a fragrance ingredient with a fruity arom Fragrance ingredient with a fruity aroma

   

3-Nonanon-1-yl acetate

3-Nonanon-1-yl acetic acid

C11H20O3 (200.1412)


3-Nonanon-1-yl acetate is a flavouring ingredient. Removed from the GRAS (Generally Recognized As Safe) list (formerly *FEMA 2566*). Flavouring ingredient [DFC]

   

Ecgoninium Methyl Ester(1+)

(1R,2R,3S,5S)-3-hydroxy-2-(methoxycarbonyl)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium

C10H18NO3 (200.1287)


Ecgoninium Methyl Ester(1+) is also known as Ecgonine methyl ester or Ecgonine methyl ester, (1R-(endo,endo))-isomer. Ecgoninium Methyl Ester(1+) is considered to be slightly soluble (in water) and relatively neutral

   

levomedetomidine

5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole

C13H16N2 (200.1313)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].

   

1-Pyrrolidinyloxy, 3-(methoxycarbonyl)-2,2,5,5-tetramethyl-

[3-(methoxycarbonyl)-2,2,5,5-tetramethylpyrrolidin-1-yl]oxidanyl

C10H18NO3 (200.1287)


   

SCHEMBL16432856

SCHEMBL16432856

C11H20O3 (200.1412)


   

EINECS 285-906-6

EINECS 285-906-6

C11H20OS (200.1235)


   

2-(2-methylpropyl)-5-phenyl-1H-imidazole

2-(2-methylpropyl)-5-phenyl-1H-imidazole

C13H16N2 (200.1313)


   

methyl 10-hydroxy-decenoate

methyl 10-hydroxy-decenoate

C11H20O3 (200.1412)


   

ACMC-20lu3p

ACMC-20lu3p

C11H20O3 (200.1412)


   

8-(3-methyloxiran-2-yl)octanoic acid

8-(3-methyloxiran-2-yl)octanoic acid

C11H20O3 (200.1412)


   

11-hydroxyundec-9-enoic acid

11-hydroxyundec-9-enoic acid

C11H20O3 (200.1412)


   

AGN-PC-0JSC21

AGN-PC-0JSC21

C11H20O3 (200.1412)


   

1H-Imidazole, 2-(1-methylpropyl)-5-phenyl-

1H-Imidazole, 2-(1-methylpropyl)-5-phenyl-

C13H16N2 (200.1313)


   

Methyl 5-oxodecanoate

Methyl 5-oxodecanoate

C11H20O3 (200.1412)


   

Leptocladine

Leptocladine

C13H16N2 (200.1313)


   
   

2-methyl-2,5,6-bornantriol

2-methyl-2,5,6-bornantriol

C11H20O3 (200.1412)


   

AKOS012000619

AKOS012000619

C11H20O3 (200.1412)


   

4-oxoundecanoic acid

4-oxoundecanoic acid

C11H20O3 (200.1412)


   

ETHYL 9-OXONONANOATE

ETHYL 9-OXONONANOATE

C11H20O3 (200.1412)


   

3-Hydroxy-2,8-dimethyl-1,7-dioxaspiro[5.5]undecane

3-Hydroxy-2,8-dimethyl-1,7-dioxaspiro[5.5]undecane

C11H20O3 (200.1412)


   

methyl 2,3-dihydrogeraniol-8-oate|methyl 8-hydroxy-2,6-dimethyl-2-(E)-octenoate

methyl 2,3-dihydrogeraniol-8-oate|methyl 8-hydroxy-2,6-dimethyl-2-(E)-octenoate

C11H20O3 (200.1412)


   

communiol E

communiol E

C11H20O3 (200.1412)


   

11-oxoundecanoic acid

11-oxoundecanoic acid

C11H20O3 (200.1412)


   

(+)-(3S*,4R*)-dihydroxy-(5R*)-methoxysabinane

(+)-(3S*,4R*)-dihydroxy-(5R*)-methoxysabinane

C11H20O3 (200.1412)


   

10-Methyl-1,11-dioxaspiro[5.5]undecane-2-methanol

10-Methyl-1,11-dioxaspiro[5.5]undecane-2-methanol

C11H20O3 (200.1412)


   

Stendomycidin

Stendomycidin

C8H16N4O2 (200.1273)


   

6-oxoundecanoic Acid

6-oxoundecanoic Acid

C11H20O3 (200.1412)


   

(E)-5-hydroxyundec-2-enoic acid

NCGC00380326-01!(E)-5-hydroxyundec-2-enoic acid

C11H20O3 (200.1412)


   

2R-hydroxy-10-undecenoic acid

10-Undecenoic acid, 2-hydroxy-, (R)-

C11H20O3 (200.1412)


   

2S-hydroxy-10-undecenoic acid

10-Undecenoic acid, 2-hydroxy-, (S)-

C11H20O3 (200.1412)


   

Pelargonyl acetic acid

Pelargonyl acetic acid

C11H20O3 (200.1412)


   

3-capryl propionic acid

3-capryl propionic acid

C11H20O3 (200.1412)


   

4-heptanoyl butyric acid

4-heptanoyl butyric acid

C11H20O3 (200.1412)


   

8-propionyl caprylic acid

8-propionyl caprylic acid

C11H20O3 (200.1412)


   

9-acetyl pelargonic acid

9-acetyl pelargonic acid

C11H20O3 (200.1412)


   

2-hydroxy-10-undecenoic acid

2-hydroxy-10-undecenoic acid

C11H20O3 (200.1412)


   

2-oxo-undecanoic acid

2-oxo-undecanoic acid

C11H20O3 (200.1412)


   

9-hydroxyundec-10-enoic Acid

(S)-9-Hydroxy-10-undecenoic acid

C11H20O3 (200.1412)


   

Clarycet

4-methyl-2-propyloxan-4-yl acetate

C11H20O3 (200.1412)


   

3-oxononyl acetate

3-Nonanon-1-yl acetate

C11H20O3 (200.1412)


   

WE(6:1(3Z)/4:0(2OH[R],3Me))

3Z-Hexenyl 2R-hydroxy-3-methylbutyrate

C11H20O3 (200.1412)


   

5R-hydroxy-4R-decanolide

(4R,5R)-5-hydroxy-4-decanolide

C11H20O3 (200.1412)


   

5S-hydroxy-4R-decanolide

(4R,5S)-5-hydroxy-4-decanolide

C11H20O3 (200.1412)


   

6-hydroxy-4-Undecanolide

6-hydroxy-4-Undecanolide

C11H20O3 (200.1412)


   

FA 11:1;O

10-Undecenoic acid, 2-hydroxy-, (S)-

C11H20O3 (200.1412)


   

WE 11:1;O

3Z-Hexenyl 2R-hydroxy-3-methylbutyrate

C11H20O3 (200.1412)


   

Silane, (6-ethoxy-3,4-dihydro-2H-pyran-5-yl)trimethyl- (9CI)

Silane, (6-ethoxy-3,4-dihydro-2H-pyran-5-yl)trimethyl- (9CI)

C10H20O2Si (200.1233)


   

Methyl 2-hexylacetoacetate

Methyl 2-hexylacetoacetate

C11H20O3 (200.1412)


   

hexoxyethyl acrylate

hexoxyethyl acrylate

C11H20O3 (200.1412)


   

1H-INDOLE, 3-(1-PYRROLIDINYLMETHYL)-

1H-INDOLE, 3-(1-PYRROLIDINYLMETHYL)-

C13H16N2 (200.1313)


   

3-Cyclohexyl-1H-pyrrolo[2,3-b]pyridine

3-Cyclohexyl-1H-pyrrolo[2,3-b]pyridine

C13H16N2 (200.1313)


   

(2R)-2-cyclopropyl-2-[[(1R)-1-phenylethyl]amino]acetonitrile

(2R)-2-cyclopropyl-2-[[(1R)-1-phenylethyl]amino]acetonitrile

C13H16N2 (200.1313)


   

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-3,3-dimethyl- (9CI)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-3,3-dimethyl- (9CI)

C13H16N2 (200.1313)


   

methyl 3-oxodecanoate

methyl 3-oxodecanoate

C11H20O3 (200.1412)


   

3-piperidin-4-yl-1H-indole

3-piperidin-4-yl-1H-indole

C13H16N2 (200.1313)


   

1-methyl-4-phenylpiperidine-4-carbonitrile

1-methyl-4-phenylpiperidine-4-carbonitrile

C13H16N2 (200.1313)


   

N,N-dimethylpiperazine-1,4-dicarboxamide

N,N-dimethylpiperazine-1,4-dicarboxamide

C8H16N4O2 (200.1273)


   

Cyclohexanecarbonitrile,1-(phenylamino)-

Cyclohexanecarbonitrile,1-(phenylamino)-

C13H16N2 (200.1313)


   

1-BUTYL-ISOQUINOLIN-3-YLAMINE

1-BUTYL-ISOQUINOLIN-3-YLAMINE

C13H16N2 (200.1313)


   

Butanoic acid,3-oxo-,heptyl ester

Butanoic acid,3-oxo-,heptyl ester

C11H20O3 (200.1412)


   

1H-Benzimidazole,1-cyclohexyl-(9CI)

1H-Benzimidazole,1-cyclohexyl-(9CI)

C13H16N2 (200.1313)


   

(1E,3Z)-1-methoxy-2-methyl-3-[(trimethylsilyl)oxy]-penta-1,3-diene

(1E,3Z)-1-methoxy-2-methyl-3-[(trimethylsilyl)oxy]-penta-1,3-diene

C10H20O2Si (200.1233)


   

1-(4-Piperidinyl)-1H-indole

1-(4-Piperidinyl)-1H-indole

C13H16N2 (200.1313)


   

2-(2-piperidyl)-1H-indole

2-(2-piperidyl)-1H-indole

C13H16N2 (200.1313)


   

4,4-(2H2)Methylenedianiline

4,4-(2H2)Methylenedianiline

C13H12D2N2 (200.1282)


   

Methyl 10-oxodecanoate

Methyl 10-oxodecanoate

C11H20O3 (200.1412)


   

1H-Benzimidazole,2-(1-methylethyl)-1-(2-propenyl)-(9CI)

1H-Benzimidazole,2-(1-methylethyl)-1-(2-propenyl)-(9CI)

C13H16N2 (200.1313)


   

3-(4-HYDROXY-CYCLOHEXYL)-PROPIONIC ACID ETHYL ESTER

3-(4-HYDROXY-CYCLOHEXYL)-PROPIONIC ACID ETHYL ESTER

C11H20O3 (200.1412)


   

4-[2-(2,6-DIMETHYL-PHENYL)-ETHYL]-1H-IMIDAZOLE

4-[2-(2,6-DIMETHYL-PHENYL)-ETHYL]-1H-IMIDAZOLE

C13H16N2 (200.1313)


   
   

12-chloro-5-dodecyne

12-chloro-5-dodecyne

C12H21Cl (200.1332)


   

3-tert-butylisoquinolin-1-amine

3-tert-butylisoquinolin-1-amine

C13H16N2 (200.1313)


   

3-(2,5-Dimethyl-pyrrol-1-yl)-4-methyl-phenylamine

3-(2,5-Dimethyl-pyrrol-1-yl)-4-methyl-phenylamine

C13H16N2 (200.1313)


   

Benzenamine, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-3-methyl- (9CI)

Benzenamine, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-3-methyl- (9CI)

C13H16N2 (200.1313)


   

Cyclopentanemethanol, 2-[(tetrahydro-2H-pyran-2-yl)oxy]- (9CI)

Cyclopentanemethanol, 2-[(tetrahydro-2H-pyran-2-yl)oxy]- (9CI)

C11H20O3 (200.1412)


   

C-(6,7,8,9-TETRAHYDRO-5 H-CARBAZOL-3-YL)-METHYLAMINE

C-(6,7,8,9-TETRAHYDRO-5 H-CARBAZOL-3-YL)-METHYLAMINE

C13H16N2 (200.1313)


   

(5S)-5,6-DIHYDRO-5,6-DIHYDROXY-6-METHYLHEPTAN-2-ONE ACETONIDE

(5S)-5,6-DIHYDRO-5,6-DIHYDROXY-6-METHYLHEPTAN-2-ONE ACETONIDE

C11H20O3 (200.1412)


   

Ethyl 4-carbamimidoylpiperazine-1-carboxylate

Ethyl 4-carbamimidoylpiperazine-1-carboxylate

C8H16N4O2 (200.1273)


   

3-Trimethylsilylpropargyl aldehyde diethyl acetal

3-Trimethylsilylpropargyl aldehyde diethyl acetal

C10H20O2Si (200.1233)


   

1-(Piperidin-4-yl)-1H-indole

1-(Piperidin-4-yl)-1H-indole

C13H16N2 (200.1313)


   

[(Z)-(1,3-dihydroxy-2,2,5,5-tetramethylimidazolidin-4-ylidene)methyl]diazene

[(Z)-(1,3-dihydroxy-2,2,5,5-tetramethylimidazolidin-4-ylidene)methyl]diazene

C8H16N4O2 (200.1273)


   

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-4,9-dimethyl- (9CI)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-4,9-dimethyl- (9CI)

C13H16N2 (200.1313)


   

9-methyl-8-oxodecanoic acid

9-methyl-8-oxodecanoic acid

C11H20O3 (200.1412)


   

2-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole

2-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole

C13H16N2 (200.1313)


   

Cyclohexanecarbothioicacid, S-(1,1-dimethylethyl) ester

Cyclohexanecarbothioicacid, S-(1,1-dimethylethyl) ester

C11H20OS (200.1235)


   

1-benzylpiperidine-3-carbonitrile

1-benzylpiperidine-3-carbonitrile

C13H16N2 (200.1313)


   

1H-Benzimidazole,2-cyclohexyl-(9CI)

1H-Benzimidazole,2-cyclohexyl-(9CI)

C13H16N2 (200.1313)


   

2-Ethyl-1-(2-methyl-2-propen-1-yl)-1H-benzimidazole

2-Ethyl-1-(2-methyl-2-propen-1-yl)-1H-benzimidazole

C13H16N2 (200.1313)


   

ETHYL 2-ACETYL-5-METHYLHEXANOATE

ETHYL 2-ACETYL-5-METHYLHEXANOATE

C11H20O3 (200.1412)


   

8-propan-2-yloxy-1,4-dioxaspiro[4.5]decane

8-propan-2-yloxy-1,4-dioxaspiro[4.5]decane

C11H20O3 (200.1412)


   

1-BENZYL-4-METHYL-PYRROLIDINE-3-CARBONITRILE

1-BENZYL-4-METHYL-PYRROLIDINE-3-CARBONITRILE

C13H16N2 (200.1313)


   

3-PIPERIDIN-2-YL-1H-INDOLE

3-PIPERIDIN-2-YL-1H-INDOLE

C13H16N2 (200.1313)


   

Tempo carboxylic acid

4-Carboxy-2,2,6,6-tetramethylpiperidine-N-oxyl

C10H18NO3 (200.1287)


   

Thiourea, N-cyclopentyl-N-(1-methylpropyl)- (9CI)

Thiourea, N-cyclopentyl-N-(1-methylpropyl)- (9CI)

C10H20N2S (200.1347)


   

Thiourea, N-cyclopentyl-N-(1,1-dimethylethyl)- (9CI)

Thiourea, N-cyclopentyl-N-(1,1-dimethylethyl)- (9CI)

C10H20N2S (200.1347)


   

6-(PIPERIDIN-4-YL)-1H-INDOLE

6-(PIPERIDIN-4-YL)-1H-INDOLE

C13H16N2 (200.1313)


   

Thiourea, N-cyclopentyl-N-(2-methylpropyl)- (9CI)

Thiourea, N-cyclopentyl-N-(2-methylpropyl)- (9CI)

C10H20N2S (200.1347)


   

2-piperidin-4-yl-1H-indole

2-piperidin-4-yl-1H-indole

C13H16N2 (200.1313)


   

1-Piperidineacetonitrile,a-phenyl-

1-Piperidineacetonitrile,a-phenyl-

C13H16N2 (200.1313)


   

3-(3-Piperidinyl)-1H-indole

3-(3-Piperidinyl)-1H-indole

C13H16N2 (200.1313)


   

1-Benzyl-3-methylpyrrolidine-3-carbonitrile

1-Benzyl-3-methylpyrrolidine-3-carbonitrile

C13H16N2 (200.1313)


   

TRANS-4-(DIETHYLAMINO)CINNAMONITRILE

TRANS-4-(DIETHYLAMINO)CINNAMONITRILE

C13H16N2 (200.1313)


   

1,4-cyclohexanedicarbohydrazide

1,4-cyclohexanedicarbohydrazide

C8H16N4O2 (200.1273)


   

2-(dimethoxymethylsilyl)-bicyclo[2,2,1]heptanes

2-(dimethoxymethylsilyl)-bicyclo[2,2,1]heptanes

C10H20O2Si (200.1233)


   

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-2,2-dimethyl- (9CI)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-2,2-dimethyl- (9CI)

C13H16N2 (200.1313)


   

1-Benzyl-4-piperidinecarbonitrile

1-Benzyl-4-piperidinecarbonitrile

C13H16N2 (200.1313)


   

1H-Imidazole,1-(3,4-dimethylphenyl)-2-ethyl-(9CI)

1H-Imidazole,1-(3,4-dimethylphenyl)-2-ethyl-(9CI)

C13H16N2 (200.1313)


   

1-Allyl-2-propyl-1H-benzimidazole

1-Allyl-2-propyl-1H-benzimidazole

C13H16N2 (200.1313)


   

1H-Benzimidazole,5,6-dimethyl-1-(2-methyl-2-propenyl)-(9CI)

1H-Benzimidazole,5,6-dimethyl-1-(2-methyl-2-propenyl)-(9CI)

C13H16N2 (200.1313)


   

(t-Butyldimethylsilyloxy)cyclopropanecarbaldehyde

(t-Butyldimethylsilyloxy)cyclopropanecarbaldehyde

C10H20O2Si (200.1233)


   

2,8-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole

2,8-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole

C13H16N2 (200.1313)


   

UNII:S67X93ZTKQ

UNII:S67X93ZTKQ

C11H20O3 (200.1412)


   

1-ETHYL-2,3,4,9-TETRAHYDRO-1H-β-CARBOLINE

1-ETHYL-2,3,4,9-TETRAHYDRO-1H-β-CARBOLINE

C13H16N2 (200.1313)


   

5-Oxoundecanoic acid

5-Oxoundecanoic acid

C11H20O3 (200.1412)


   

10-Oxoundecanoic acid

10-Oxoundecanoic acid

C11H20O3 (200.1412)


   

LevoMedetoMidine

LevoMedetoMidine

C13H16N2 (200.1313)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

3-Oxoundecanoic acid

3-Oxoundecanoic acid

C11H20O3 (200.1412)


   

9-Oxoundecanoic acid

9-Oxoundecanoic acid

C11H20O3 (200.1412)


   

2-Oxoundecanoic acid

2-Oxoundecanoic acid

C11H20O3 (200.1412)


   

11-Hydroxy-2-undecenoic acid

11-Hydroxy-2-undecenoic acid

C11H20O3 (200.1412)


   

2,5-Dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole

2,5-Dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole

C13H16N2 (200.1313)


   

Trimethylsilyl cyclohexanecarboxylate

Trimethylsilyl cyclohexanecarboxylate

C10H20O2Si (200.1233)


   

1-Benzyl-3,4,5-trimethyl-1H-pyrazole

1-Benzyl-3,4,5-trimethyl-1H-pyrazole

C13H16N2 (200.1313)


   

PYRIMIDO(3,4-a)INDOLE, 1,2,3,4-TETRAHYDRO-5,7-DIMETHYL-

PYRIMIDO(3,4-a)INDOLE, 1,2,3,4-TETRAHYDRO-5,7-DIMETHYL-

C13H16N2 (200.1313)


   

4-Benzyl-1,3,5-trimethyl-1H-pyrazole

4-Benzyl-1,3,5-trimethyl-1H-pyrazole

C13H16N2 (200.1313)


   

Hexyl levulinate

Hexyl levulinate

C11H20O3 (200.1412)


   

4-Benzyl-3,4,5-trimethyl-4H-pyrazole

4-Benzyl-3,4,5-trimethyl-4H-pyrazole

C13H16N2 (200.1313)


   

3-(2-Aminoethyl)-1,7-ethylene-2-methylindole

3-(2-Aminoethyl)-1,7-ethylene-2-methylindole

C13H16N2 (200.1313)


   

Methyl ecgonine

Methyl ecgonine

C10H18NO3+ (200.1287)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoate methyl ester

4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoate methyl ester

C10H18NO3+ (200.1287)


   

6-methyl-2,3,4,5-tetrahydro-1H-azepino[4,5-b]indole

6-methyl-2,3,4,5-tetrahydro-1H-azepino[4,5-b]indole

C13H16N2 (200.1313)


   

(Octanoylamino)acetate

(Octanoylamino)acetate

C10H18NO3- (200.1287)


   

O-formyldecanoate

O-formyldecanoate

C11H20O3 (200.1412)


   

(E)-5-Hydroxyundec-2-enoic acid

(E)-5-Hydroxyundec-2-enoic acid

C11H20O3 (200.1412)


   

Ethyl (E)-8-hydroxynon-2-enoate

Ethyl (E)-8-hydroxynon-2-enoate

C11H20O3 (200.1412)


   

(2E,10R)-10-hydroxyundec-2-enoic acid

(2E,10R)-10-hydroxyundec-2-enoic acid

C11H20O3 (200.1412)


An (omega-1)-hydroxy fatty acid that is trans-undec-2-enoic acid in which the 10-pro-R hydrogen is replaced by a hydroxy group.

   

(Z)-1,4-Bistrimethylsilyl-2-butene

(Z)-1,4-Bistrimethylsilyl-2-butene

C10H24Si2 (200.1416)


   

3,8-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

3,8-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C13H16N2 (200.1313)


   

2-Heptenoic acid,trimethylsilyl ester

2-Heptenoic acid,trimethylsilyl ester

C10H20O2Si (200.1233)


   

7-(1,3-Dioxan-2-yl)heptanal

7-(1,3-Dioxan-2-yl)heptanal

C11H20O3 (200.1412)


   

Cyclopentylacetic acid trimethylsilyl ester

Cyclopentylacetic acid trimethylsilyl ester

C10H20O2Si (200.1233)


   

3-Ethyl-1,2,3,4-tetrahydro-gamma-carboline

3-Ethyl-1,2,3,4-tetrahydro-gamma-carboline

C13H16N2 (200.1313)


   

3,6-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

3,6-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C13H16N2 (200.1313)


   

2,2-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

2,2-Dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C13H16N2 (200.1313)


   

1,1-Diethoxy-2-heptyn-4-ol

1,1-Diethoxy-2-heptyn-4-ol

C11H20O3 (200.1412)


   

1,2-Dibutyl-1,2-dimethyldisilane

1,2-Dibutyl-1,2-dimethyldisilane

C10H24Si2 (200.1416)


   

tetrahydrozoline

tetrahydrozoline

C13H16N2 (200.1313)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].

   

Dexmedetomidine

Dexmedetomidine

C13H16N2 (200.1313)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3].

   

3-Nonanon-1-yl acetate

3-Nonanon-1-yl acetate

C11H20O3 (200.1412)


   

(S)-9-Hydroxy-10-undecenoic acid

(S)-9-Hydroxy-10-undecenoic acid

C11H20O3 (200.1412)


   

N-octanoylglycinate

N-octanoylglycinate

C10H18NO3 (200.1287)


An N-acylglycinate resulting from the deprotonation of the carboxy group of N-octanoylglycine. The conjugate base of N-octanoylglycine; major species at pH 7.3.

   

3Z-Hexenyl 2R-hydroxy-3-methylbutyrate

3Z-Hexenyl 2R-hydroxy-3-methylbutyrate

C11H20O3 (200.1412)


   

(2E)-11-hydroxyundec-2-enoic acid

(2E)-11-hydroxyundec-2-enoic acid

C11H20O3 (200.1412)


An omega-hydroxy fatty acid that is trans-undec-2-enoic acid in which one of the hydrogens attached to the terminal methyl group is replaced by a hydroxy group.

   

10-Undecenoic acid, 2-hydroxy-, (S)-

10-Undecenoic acid, 2-hydroxy-, (S)-

C11H20O3 (200.1412)


   

Ecgoninium Methyl Ester(1+)

Ecgoninium Methyl Ester(1+)

C10H18NO3 (200.1287)


The conjugate acid of ecgonine methyl ester arising from protonation of the tertiary amino group; major species at pH 7.3.

   

Hydroxyundecenoic acid

Hydroxyundecenoic acid

C11H20O3 (200.1412)


   

1-isopropyl-4-methoxy-4-methylbicyclo[3.1.0]hexane-2,3-diol

1-isopropyl-4-methoxy-4-methylbicyclo[3.1.0]hexane-2,3-diol

C11H20O3 (200.1412)


   

(1s)-1-[(2s,3ar,6r,6as)-6-(hydroxymethyl)-hexahydro-2h-cyclopenta[b]furan-2-yl]propan-1-ol

(1s)-1-[(2s,3ar,6r,6as)-6-(hydroxymethyl)-hexahydro-2h-cyclopenta[b]furan-2-yl]propan-1-ol

C11H20O3 (200.1412)


   

methyl 8-hydroxy-2,6-dimethyloct-2-enoate

methyl 8-hydroxy-2,6-dimethyloct-2-enoate

C11H20O3 (200.1412)


   

(3r,4r,5s)-3-hexyl-4-hydroxy-5-methyloxolan-2-one

(3r,4r,5s)-3-hexyl-4-hydroxy-5-methyloxolan-2-one

C11H20O3 (200.1412)


   

4,5,7,7-tetramethylbicyclo[2.2.1]heptane-2,3,5-triol

4,5,7,7-tetramethylbicyclo[2.2.1]heptane-2,3,5-triol

C11H20O3 (200.1412)


   

2-(but-2-en-1-ylidene)heptane-1,3,4-triol

2-(but-2-en-1-ylidene)heptane-1,3,4-triol

C11H20O3 (200.1412)


   

(2s,3s,6r,8s)-2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

(2s,3s,6r,8s)-2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

C11H20O3 (200.1412)


   

1,2-dimethyl-1h,3h,4h,9h-pyrido[3,4-b]indole

1,2-dimethyl-1h,3h,4h,9h-pyrido[3,4-b]indole

C13H16N2 (200.1313)


   

2-[(2e)-but-2-en-1-ylidene]heptane-1,3,4-triol

2-[(2e)-but-2-en-1-ylidene]heptane-1,3,4-triol

C11H20O3 (200.1412)


   

2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

C11H20O3 (200.1412)


   

1-[6-(hydroxymethyl)-hexahydro-2h-cyclopenta[b]furan-2-yl]propan-1-ol

1-[6-(hydroxymethyl)-hexahydro-2h-cyclopenta[b]furan-2-yl]propan-1-ol

C11H20O3 (200.1412)


   

(1r,2s,3r,4s,5r)-4,5,7,7-tetramethylbicyclo[2.2.1]heptane-2,3,5-triol

(1r,2s,3r,4s,5r)-4,5,7,7-tetramethylbicyclo[2.2.1]heptane-2,3,5-triol

C11H20O3 (200.1412)


   

undeca-7,9-diene-2,4,5-triol

undeca-7,9-diene-2,4,5-triol

C11H20O3 (200.1412)


   

(2s,3r,6r,8s)-2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

(2s,3r,6r,8s)-2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-3-ol

C11H20O3 (200.1412)


   

methyl (2e,6s)-8-hydroxy-2,6-dimethyloct-2-enoate

methyl (2e,6s)-8-hydroxy-2,6-dimethyloct-2-enoate

C11H20O3 (200.1412)


   

9-oxononyl acetate

9-oxononyl acetate

C11H20O3 (200.1412)


   

3-hexyl-4-hydroxy-5-methyloxolan-2-one

3-hexyl-4-hydroxy-5-methyloxolan-2-one

C11H20O3 (200.1412)


   

(1r,2s,3r,4r,5r)-1-isopropyl-4-methoxy-4-methylbicyclo[3.1.0]hexane-2,3-diol

(1r,2s,3r,4r,5r)-1-isopropyl-4-methoxy-4-methylbicyclo[3.1.0]hexane-2,3-diol

C11H20O3 (200.1412)


   

[2-(4-hydroxy-4-methylpentyl)cyclopropyl]acetic acid

[2-(4-hydroxy-4-methylpentyl)cyclopropyl]acetic acid

C11H20O3 (200.1412)


   

(1r)-1,2-dimethyl-1h,3h,4h,9h-pyrido[3,4-b]indole

(1r)-1,2-dimethyl-1h,3h,4h,9h-pyrido[3,4-b]indole

C13H16N2 (200.1313)


   

(4s,5s)-4-hydroxy-4-(2-hydroxyethyl)-3,3,5-trimethylcyclohexan-1-one

(4s,5s)-4-hydroxy-4-(2-hydroxyethyl)-3,3,5-trimethylcyclohexan-1-one

C11H20O3 (200.1412)


   

(7e,9e)-undeca-7,9-diene-2,4,5-triol

(7e,9e)-undeca-7,9-diene-2,4,5-triol

C11H20O3 (200.1412)


   

(2z,3r,4s)-2-[(2e)-but-2-en-1-ylidene]heptane-1,3,4-triol

(2z,3r,4s)-2-[(2e)-but-2-en-1-ylidene]heptane-1,3,4-triol

C11H20O3 (200.1412)